187 related articles for article (PubMed ID: 35331925)
1. Engineering nanobodies for next-generation molecular imaging.
Yang E; Liu Q; Huang G; Liu J; Wei W
Drug Discov Today; 2022 Jun; 27(6):1622-1638. PubMed ID: 35331925
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
3. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.
Massa S; Vikani N; Betti C; Ballet S; Vanderhaegen S; Steyaert J; Descamps B; Vanhove C; Bunschoten A; van Leeuwen FW; Hernot S; Caveliers V; Lahoutte T; Muyldermans S; Xavier C; Devoogdt N
Contrast Media Mol Imaging; 2016 Sep; 11(5):328-339. PubMed ID: 27147480
[TBL] [Abstract][Full Text] [Related]
4. Design and Validation of Site-Specifically Labeled Single-Domain Antibody-Based Tracers for in Vivo Fluorescence Imaging and Image-Guided Surgery.
Declerck NB; Mateusiak L; Hernot S
Methods Mol Biol; 2022; 2446():395-407. PubMed ID: 35157285
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
[TBL] [Abstract][Full Text] [Related]
6. Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.
Xiao Y; Mei C; Xu D; Yang F; Yang M; Bi L; Mao J; Pang P; Li D
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2305-2318. PubMed ID: 36914753
[TBL] [Abstract][Full Text] [Related]
7. ImmunoPET: Concept, Design, and Applications.
Wei W; Rosenkrans ZT; Liu J; Huang G; Luo QY; Cai W
Chem Rev; 2020 Apr; 120(8):3787-3851. PubMed ID: 32202104
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Bannas P; Lenz A; Kunick V; Well L; Fumey W; Rissiek B; Haag F; Schmid J; Schütze K; Eichhoff A; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2015; 10(5):367-78. PubMed ID: 25925493
[TBL] [Abstract][Full Text] [Related]
9. Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging.
Hebbrecht T; Liu J; Zwaenepoel O; Boddin G; Van Leene C; Decoene K; Madder A; Braeckmans K; Gettemans J
N Biotechnol; 2020 Nov; 59():33-43. PubMed ID: 32659511
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
11. Nanobody: the "magic bullet" for molecular imaging?
Chakravarty R; Goel S; Cai W
Theranostics; 2014; 4(4):386-98. PubMed ID: 24578722
[TBL] [Abstract][Full Text] [Related]
12. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
13. An efficient method for the site-specific
Luo Q; Gao H; Shi J; Wang F
Biophys Rep; 2021 Aug; 7(4):295-303. PubMed ID: 37287762
[TBL] [Abstract][Full Text] [Related]
14. Employing nanobodies for immune landscape profiling by PET imaging in mice.
Teunissen AJP; Abousaway OB; Munitz J; van Leent MMT; Toner YC; Priem B; Senders ML; Pérez-Medina C; Mulder WJM; Rashidian M
STAR Protoc; 2021 Jun; 2(2):100434. PubMed ID: 33899016
[TBL] [Abstract][Full Text] [Related]
15. Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.
Bannas P; Lenz A; Kunick V; Fumey W; Rissiek B; Schmid J; Haag F; Leingärtner A; Trepel M; Adam G; Koch-Nolte F
J Vis Exp; 2015 Apr; (98):e52462. PubMed ID: 25867711
[TBL] [Abstract][Full Text] [Related]
16. ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical reality.
Dun Y; Huang G; Liu J; Wei W
Drug Discov Today; 2022 Apr; 27(4):1196-1203. PubMed ID: 34838729
[TBL] [Abstract][Full Text] [Related]
17. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging using Nanobodies: a case study.
Devoogdt N; Xavier C; Hernot S; Vaneycken I; D'Huyvetter M; De Vos J; Massa S; De Baetselier P; Caveliers V; Lahoutte T
Methods Mol Biol; 2012; 911():559-67. PubMed ID: 22886276
[TBL] [Abstract][Full Text] [Related]
19. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.
Adumeau P; Sharma SK; Brent C; Zeglis BM
Mol Imaging Biol; 2016 Feb; 18(1):1-17. PubMed ID: 26754790
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]